NYSE - Delayed Quote USD

Perrigo Company plc (PRGO)

27.60
+1.43
+(5.46%)
At close: June 10 at 4:00:02 PM EDT
27.01
-0.59
(-2.14%)
After hours: June 10 at 6:40:00 PM EDT
Loading Chart for PRGO
  • Previous Close 26.17
  • Open 26.36
  • Bid --
  • Ask --
  • Day's Range 26.18 - 27.74
  • 52 Week Range 23.14 - 30.93
  • Volume 1,539,566
  • Avg. Volume 1,459,200
  • Market Cap (intraday) 3.794B
  • Beta (5Y Monthly) 0.45
  • PE Ratio (TTM) --
  • EPS (TTM) -1.27
  • Earnings Date Aug 4, 2025 - Aug 18, 2025
  • Forward Dividend & Yield 1.16 (4.43%)
  • Ex-Dividend Date May 30, 2025
  • 1y Target Est 36.50

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

www.perrigo.com

8,379

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PRGO

View More

Performance Overview: PRGO

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PRGO
8.45%
S&P 500 (^GSPC)
2.67%

1-Year Return

PRGO
4.26%
S&P 500 (^GSPC)
12.65%

3-Year Return

PRGO
21.38%
S&P 500 (^GSPC)
54.81%

5-Year Return

PRGO
40.40%
S&P 500 (^GSPC)
89.30%

Compare To: PRGO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRGO

View More

Valuation Measures

Annual
As of 6/10/2025
  • Market Cap

    3.79B

  • Enterprise Value

    7.01B

  • Trailing P/E

    --

  • Forward P/E

    8.64

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    0.82

  • Enterprise Value/Revenue

    1.57

  • Enterprise Value/EBITDA

    12.75

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.16%

  • Return on Assets (ttm)

    2.93%

  • Return on Equity (ttm)

    -3.64%

  • Revenue (ttm)

    4.34B

  • Net Income Avi to Common (ttm)

    -164.7M

  • Diluted EPS (ttm)

    -1.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    409.9M

  • Total Debt/Equity (mrq)

    87.89%

  • Levered Free Cash Flow (ttm)

    379.52M

Research Analysis: PRGO

View More

Company Insights: PRGO

Research Reports: PRGO

View More

People Also Watch